Amneal Receives U.S. FDA Approval For Propofol Injectable Emulsion Single Dose Vials
Details : Diprivan-Generic (propofol) is approved in the US, which is an intravenous drug commonly used in hospitals for the induction and maintenance of anesthesia and sedation.
Brand Name : Diprivan-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 20, 2024
Details : Propofol is an intravenous general anesthetic and sedation drug for use in the induction and maintenance of anesthesia or sedation. Propofol Injectable Emulsion is a terminally sterilized (TS) product.
Brand Name : Propofol-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 22, 2022
Details : Propofol is an intravenous general anesthetic and sedation drug for use in the induction and maintenance of anesthesia or sedation. Propofol Injectable Emulsion, USP is a terminally sterilized (TS) product.
Brand Name : Propofol-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
July 13, 2022
Avet Pharmaceuticals Announces Approval and Launch of Propofol Injectable Emulsion, USP
Details : Propofol injectable emulsion, an AB-rated generic equivalent of DIPRIVAN® (propofol) Injectable Emulsion USP is an intravenous general anesthetic and sedation drug indicated for initiation and maintenance of Monitored Anesthesia Care (MAC) sedation.
Brand Name : Propofol-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
April 07, 2022
Details : Premier through its ProvideGx™ program, has partnered with Fresenius Kabi to supply Diprivan® (propofol) injectable emulsion, USP to healthcare providers, helping to stabilize the long-term supply of a medication vital for COVID-19 patient care.
Brand Name : Diprivan
Molecule Type : Small molecule
Upfront Cash : Undisclosed
July 13, 2020
LOOKING FOR A SUPPLIER?
Reset All
